Organization Overview
Historical Acquisition Tree
Alternative names
Key: Genzyme (14) Acquired (2)
agalsidase beta (fabrazyme) (2003 NDA)
alemtuzumab (campath) (2001)
alglucerase (ceredase) (1991 NDA)
alglucosidase alfa (myozyme) (2006 NDA)
clofarabine (clolar) (2004 NDA)
eliglustat (cerdelga) (2014 NDA)
fludarabine (fludara) (1991 NDA)
gz402666 (2021)
imiglucerase (cerezyme) (1994 NDA)
leuprolide (lupron) (2001)
mipomersen (kynamro) (2013 NDA)
olipudase alfa (Xenpozyme) (2022)
plerixafor (mozobil) (2008 NDA)
sevelamer (renagel) (1998)
thyrotropin alfa (thyrogen) (1998)
vandetanib (caprelsa) (2011)
Key: Genzyme (34) Acquired (4)
acetaminophen (tylenol) (4 trials)
aciclovir (zovirax) (4 trials)
agalsidase beta (fabrazyme) (14 trials)
alemtuzumab (campath) (34 trials)
alglucosidase alfa (myozyme) (30 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (35 trials)
autologous culture chondrocytes (Carticel) (4 trials)
cetirizine (zyrtec) (3 trials)
colesevelam (welchol) (3 trials)
doxercalciferol (hectorol) (7 trials)
dupilumab (dupixent) (1 trial)
esomeprazole (nexium) (1 trial)
Key: Genzyme (38) Acquired (6)
agalsidase alfa (Replagal) (1 trial)
aldesleukin (proleukin) (2 trials)
allogeneic prostate vaccine (1 trial)
antihemophilic factor viii (Recombinant) (Adynovate) (1 trial)
anti-inhibitor coagulant complex (activated prothrombin complex concentrate) (Autoplex-T) (1 trial)
clofarabine (clolar) (60 trials)
coagulation factor ix (Recombinant) (Rixubis) (1 trial)
coagulation factor viia (recombinant) (NovoSevenRT) (1 trial)
cytarabine (cytosar-u) (13 trials)
daunorubicin (cerubidine) (2 trials)
dexchlorpheniramine maleate (polaramine) (2 trials)
diphenhydramine (benadryl) (1 trial)
docetaxel (taxotere) (11 trials)
eflornithine (ornidyl) (1 trial)
eliglustat (cerdelga) (10 trials)
etoposide (vepesid) (3 trials)
glatiramer acetate (copaxone) (1 trial)
gvax prostate cancer vaccine (6 trials)
hylan g-f 20 (gz/sar402662) (1 trial)
interferon beta-1b (betaseron) (3 trials)
levobupivacaine (chirocaine) (1 trial)
lidocaine (xylocaine) (1 trial)
olipudase alfa (Xenpozyme) (3 trials)
peginterferon beta-1a (Plegridy) (1 trial)
pemetrexed (alimta) (2 trials)
prednisolone (hydeltra) (1 trial)
prilocaine (citanest) (1 trial)
sodium polystyrene sulfonate (kayexalate) (4 trials)
teriflunomide (aubagio) (4 trials)
tolevamer potassium sodium (1 trial)
Key: Genzyme (64) Acquired (11)
4'-hydroxydesazadesferrithiocin (1 trial)
allogeneic dendritic cells (1 trial)
allogeneic stem cells (4 trials)
apomorphine (apokyn) (3 trials)
autologous rcc tumor derived cells (1 trial)
autologous skeletal myoblast (1 trial)
autologous tumor cells (1 trial)
azathioprine (imuran) (1 trial)
betamethasone (celestone) (1 trial)
bicalutamide (casodex) (1 trial)
cabazitaxel (jevtana kit) (1 trial)
carboplatin (paraplatin) (1 trial)
cyclophosphamide (cytoxan) (10 trials)
decitabine (dacogen) (3 trials)
deferoxamine (desferal) (1 trial)
dendritic cell-gp100-mart-1 antigen vaccine (1 trial)
dendritic cell tumor fusion vaccine (1 trial)
doxorubicin (Doxil) (3 trials)
electrofusion dc vaccine (1 trial)
filgrastim (neupogen) (1 trial)
gabapentin (neurontin) (1 trial)
gemcitabine (gemzar) (3 trials)
gp-100 peptide vaccine (1 trial)
gvax pancreatic cancer vaccine (3 trials)
idarubicin (idamycin) (3 trials)
ipilimumab (yervoy) (2 trials)
irinotecan (Camptosar) (2 trials)
mercaptopurine (purinethol) (1 trial)
mitoxantrone (novantrone) (1 trial)
oxaliplatin (eloxatin) (2 trials)
pegaspargase (oncaspar) (1 trial)
peripheral blood hematopoietic cell (3 trials)
pomalidomide (pomalyst) (1 trial)
thyrotropin (thyropar) (3 trials)
trilostane (modrastane) (1 trial)
Key: Genzyme (25) Acquired (2)
cisplatin (platinol) (1 trial)
colestipol (colestid) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 2)
Acute Disease (Phase 1)
Adenocarcinoma (Phase 2)
Amino Acid Metabolism, Inborn Errors (Phase 2)
Anemia (Phase 2)
Anemia, Aplastic (Phase 2)
Aphasia, Primary Progressive (Phase 1)
Astrocytoma (Phase 1)
Atherosclerosis (Phase 2)
beta-Thalassemia (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Blast Crisis (Phase 2)
Brain Neoplasms (Phase 2)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoma (Phase 3)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Medullary (Phase 2)
Carcinoma, Neuroendocrine (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Cardiomyopathies (Phase 2)
Cardiovascular Diseases (Phase 2)
Cartilage Diseases (Phase 3)
Cholangiocarcinoma (Phase 2)
Clostridium Infections (Phase 3)
Colitis (Phase 3)
Colorectal Neoplasms (Phase 2)
Congenital Abnormalities (Phase 3)
Coronary Artery Disease (Phase 3)
Coronary Disease (Phase 3)
Crohn Disease (Phase 3)
Deficiency Diseases (Phase 4)
Delayed Graft Function (Phase 2)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetic Foot (Phase 1)
Diabetic Nephropathies (Phase 3)
Diarrhea (Phase 3)
Disease (Phase 3)
Dyslipidemias (Phase 3)
Endometrial Neoplasms (Phase 2)
Enterocolitis (Phase 3)
Enterocolitis, Pseudomembranous (Phase 3)
Eye Diseases (Phase 1)
Fabry Disease (Phase 4)
Fallopian Tube Neoplasms (Phase 2)
Fibrosis (Phase 1)
Foot Ulcer (Phase 1)
Fractures, Stress (Phase 3)
Frontotemporal Dementia (Phase 1)
Gallbladder Neoplasms (Phase 2)
Gaucher Disease (Phase 4)
Genetic Diseases, Inborn (Phase 3)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Gliosarcoma (Phase 1)
Glomerulosclerosis, Focal Segmental (Phase 2)
Glycogen Storage Disease (Phase 4)
Glycogen Storage Disease Type II (Phase 4)
Goiter (Phase 2)
Graft vs Host Disease (Phase 2)
Heart Diseases (Phase 3)
Heart Failure (Phase 2)
Hemophilia A (Phase 3)
Hemophilia B (Phase 3)
HIV Infections (Phase 1)
Hodgkin Disease (Phase 3)
Hypercholesterolemia (Phase 4)
Hyperlipidemias (Phase 3)
Hyperlipoproteinemias (Phase 3)
Hyperlipoproteinemia Type II (Phase 4)
Hyperparathyroidism (Phase 4)
Hyperparathyroidism, Secondary (Phase 4)
Hyperphosphatemia (Phase 3)
Hypobetalipoproteinemias (Phase 2)
Hypolipoproteinemias (Phase 2)
Hypoxia (Phase 2)
Idiopathic Pulmonary Fibrosis (Phase 1)
Immunoblastic Lymphadenopathy (Phase 2)
Infant, Newborn, Diseases (Phase 3)
Intermittent Claudication (Phase 2)
Iron Overload (Phase 2)
Ischemia (Phase 3)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Leukemia (Phase 4)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Prolymphocytic (Phase 2)
Leukemia, Prolymphocytic, T-Cell (Phase 2)
Leukemia, Promyelocytic, Acute (Phase 1)
Lipid Metabolism Disorders (Phase 3)
Lipid Metabolism, Inborn Errors (Phase 3)
Lipidoses (Phase 4)
Liver Diseases (Phase 4)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Macular Degeneration (Phase 1)
Melanoma (Phase 3)
Mesothelioma (Phase 2)
Metabolic Diseases (Phase 3)
Metabolism, Inborn Errors (Phase 3)
Mucopolysaccharidoses (Phase 4)
Mucopolysaccharidosis I (Phase 4)
Multiple Endocrine Neoplasia Type 2a (Phase 2)
Multiple Myeloma (Phase 3)
Multiple Sclerosis (Phase 4)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Muscular Dystrophies (Phase 3)
Muscular Dystrophy, Duchenne (Phase 3)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 1)
Myocardial Ischemia (Phase 3)
Neoplasm Metastasis (Phase 4)
Neoplasm, Residual (Phase 2)
Neoplasms (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neovascularization, Pathologic (Phase 1)
Nerve Degeneration (Phase 4)
Neuralgia (Phase 2)
Neuroblastoma (Phase 2)
Niemann-Pick Diseases (Phase 3)
Niemann-Pick Disease, Type A (Phase 3)
Niemann-Pick Disease, Type C (Phase 3)
Oligodendroglioma (Phase 1)
Osteoarthritis (Phase 4)
Osteoarthritis, Knee (Phase 4)
Osteogenesis Imperfecta (Phase 1)
Osteoporosis (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Paraproteinemias (Phase 2)
Parkinson Disease (Phase 2)
Peripheral Arterial Disease (Phase 2)
Peripheral Vascular Diseases (Phase 2)
Pick Disease of the Brain (Phase 1)
Polycystic Kidney, Autosomal Dominant (Phase 3)
Polycystic Kidney Diseases (Phase 3)
Polyradiculoneuropathy (Phase 4)
Preleukemia (Phase 2)
Primary Myelofibrosis (Phase 1)
Prostatic Neoplasms (Phase 2)
Psoriasis (Phase 2)
Pulmonary Alveolar Proteinosis (Phase 2)
Pulmonary Fibrosis (Phase 1)
Purpura (Phase 1)
Purpura, Thrombocytopenic (Phase 1)
Purpura, Thrombocytopenic, Idiopathic (Phase 1)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
Reperfusion Injury (Phase 3)
Retinal Degeneration (Phase 1)
Retinal Neovascularization (Phase 1)
Sandhoff Disease (Phase 3)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Scleroderma, Diffuse (Phase 2)
Scleroderma, Systemic (Phase 2)
Sclerosis (Phase 4)
Sezary Syndrome (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Syndrome (Phase 4)
Tay-Sachs Disease (Phase 3)
Thalassemia (Phase 2)
Thrombocytopenia (Phase 4)
Thyroid Diseases (Phase 4)
Thyroid Neoplasms (Phase 4)
Ulcer (Phase 1)
Urinary Bladder Neoplasms (Phase 3)
Vascular Calcification (Phase 4)
Vascular Diseases (Phase 3)
Virus Diseases (Phase 1)
Waldenstrom Macroglobulinemia (Phase 2)